Related Experiment Video
Updated: Aug 10, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Recent developments in the treatment of obesity-related hypertension
Tobias Pischon1, Arya M Sharma
1Franz Volhard Clinic - HELIOS-Klinikum Berlin Buch, Charité, Medical Faculty of the Humboldt University Berlin, Max Delbrück Center for Molecular Medicine, Germany.
Purpose Of Review:
Obesity is a major public health issue, and hypertension is one of the most common associated co-morbidities. Here, recent developments in the treatment of obesity-related hypertension, published during the past year, are reviewed.
Recent Findings:
Several recent studies have examined the effect of dietary and lifestyle changes on hypertension. These studies uniformly confirm that weight reduction together with salt restriction and increased physical exercise can lower blood pressure. Several studies have shown that pharmacologically induced weight reduction with orlistat or sibutramine can likewise be beneficial in the management of obese hypertensive patients. The role of surgery in obesity remains to be defined.
Summary:
Both non-pharmacologically and pharmacologically induced weight loss can lower blood pressure in obese hypertensive patients. The effects of weight loss and pharmacological management on morbidity and mortality in obese hypertensive patients remains to be addressed in prospective trials.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Heart Failure VI: Adjunct Therapies
Hypertension II: Pathophysiology
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

